You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
正海生物(300653.SZ):上半年淨利升7.89%至5501.57萬元
格隆匯 08-04 19:47

格隆匯 8 月 4日丨正海生物(300653.SZ)披露2020年半年度報告,實現營業收入1.34億元,同比增長1.35%;歸屬於上市公司股東的淨利潤5501.57萬元,同比增長7.89%;歸屬於上市公司股東的扣除非經常性損益後的淨利潤5181.29萬元,同比增長5.15%;基本每股收益0.46元。

第一季度,因受新冠肺炎疫情的影響,公司主營業務所對應的口腔科和神經外科等外科科室手術量下滑明顯,公司產品銷售受到較大影響,導致一季度收入同比下降26.96%,銷量同比下降54.21%;第二季度,國內疫情得到控制,各地區的醫院和相關科室逐步開放,但各大醫院口腔科和口腔醫院的開放相對更晚,截至報告期末尚有部分地區口腔醫院的相關科室尚未開展手術。在此情況下,公司積極開拓開發新客户、努力拓展新市場,以及同步大力推動銷售上量工作,在現場學術會議和活動有所不便的情況下,公司通過“直播”課程加大學術宣傳,至報告期末收穫了萬餘播放量,並在神經外科領域完成新開發終端醫院數量接近50家的優秀業績。

公司第二季度收入8957.73萬元,同比增加25.77%,環比增加99.68%,銷量同比增加41.56%,二季度銷售的突破性進展使得公司2020年上半年實現了正增長。在外部環境壓力較大的逆境環境中,公司全體銷售人員頂住壓力、迎難而上,二季度的銷售收入創造了單季度收入的歷史新高,為未來的進一步擴大營銷版圖和良性增長打下堅實基礎。

報告期內,公司已經完成各省級產品掛網1016個品次,相較於2019年底增加了73項。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account